Facebook Pixel

ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC (audio)

GRACEcast Lung Cancer Audio
GRACEcast Lung Cancer Audio

Dr. Edward Garon, David Geffen School of Medicine at UCLA, covers the provocative results of the novel immune checkpoint PD-L1 inhibitor MPDL3280A in advanced NSCLC.

GRACEcast Lung Cancer Audio
Not playing